United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Broad Changes To MHRA Proposed Under UK Health Bill
The UK Government has introduced sweeping reforms to the regulatory framework governing medicines and medical devices through amendments to the Health Bill currently progressing through Parliament. These proposed changes would grant the Secretary of State new powers to establish a licensing regime for medical devices and enable faster regulatory updates in response to scientific and technological advances.
United Kingdom Healthcare
BS
Burges Salmon
Article
UK Patents Court Reinforces The UK Threshold For Plausibility
The UK Patents Court has upheld Novartis' patent and SPC protecting Entresto, its blockbuster heart failure treatment combining valsartan and sacubitril, rejecting all validity challenges from generic manufacturer Accord Healthcare. The judgment provides crucial guidance on plausibility requirements where experimental data have been generated but not fully disclosed in the patent specification, clarifying when qualitative disclosure of positive results suffices without detailed numerical data.
United Kingdom IP
HL
HGF Ltd
Article
T 0847/24 – New EPO Case Law Informs Strategy For AI-Assisted Engineering Design Patents
A recent EPO Board of Appeal decision establishes critical guidance for protecting AI-assisted engineering design innovations, ruling that patent claims covering only digital model generation cannot be expanded post-grant to include physical manufacturing steps. The decision clarifies that when AI generates product designs—from data center layouts to 3D-printed components—the patent strategy must explicitly bridge the gap between computational output and manufactured reality from the outset.
European Union IP
HL
HGF Ltd
Article
Virtual And Digital Health Digest – July 2026
European regulators are accelerating AI governance frameworks while balancing innovation with patient safety in digital health. The European Commission has published voluntary codes for AI-generated content marking and appointed expert bodies to enforce the AI Act, while the UK's MHRA launches regulatory sandboxes to test AI tools in medicines development and the ICO establishes comprehensive guidance for AI-powered healthcare technologies.
United Kingdom Healthcare
AP
Arnold & Porter
Article
Cambridge Life Sciences Cluster Continues To Attract Investment
The Cambridge life sciences cluster demonstrates remarkable resilience with a significant surge in equity fundraising during the first half of 2026. Investment activity has increased not only in total capital raised but also in the number of companies successfully securing funding, reflecting deep confidence in the region's innovation ecosystem. Infrastructure developments including expanded research hubs and improved transport connectivity signal a flourishing sector poised for continued growth.
United Kingdom Healthcare
MC
Marks & Clerk
Podcast
The Business Of Beauty: From Luxury To Longevity With Lindy Firstenberg (Podcast)
This week, Kate sits down with Lindy Firstenberg, Co-Lead of the Beauty, Health & Wellness Practice at AlixPartners. From helping launch Louis Vuitton Fragrance to advising founders, retailers, investors, and global brands, Lindy has spent her career at the forefront of the industry's biggest shifts. Now, she's stepping into entrepreneurship herself, co-founding a science-backed scar repair company built around breakthrough biotechnology.
United Kingdom Consumer
A
AlixPartners
Article
Perfect Storm - Four Drivers Behind The MRNA Litigation Wave
The COVID-19 pandemic thrust mRNA technology into the global spotlight, transforming decades of foundational research into commercially valuable vaccines almost overnight. This rapid commercialization, combined with enormous revenues and a complex web of overlapping patents, has triggered an unprecedented wave of intellectual property disputes that is reshaping how value is allocated across the biotechnology industry and determining who controls access to next-generation RNA-based medicines.
United Kingdom IP
PC
Potter Clarkson
See more

Latest Videos

See more